Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07685233987653096b0316291f344e0b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dcbd4fadeccaf316420fb0a37a1e4822 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b26bb91198799d2c00160144463004c |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1241 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-07002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y603-02002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-93 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P13-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y205-01006 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P13-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12 |
filingDate |
2013-12-20^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eb3c4729c1800920b9ca10cf172d753 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b786660ca08389b0a7ab5509a6fa27b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1037e229d0e447373f15d6b1bcd15c1a |
publicationDate |
2015-11-16^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20150127034-A |
titleOfInvention |
Ergothioneine production through metabolic engineering |
abstract |
The present invention relates to the production of ergothionein through in vitro enzymatic transformation or fermentation using microorganisms produced by metabolic engineering. Transgenic cells useful in such methods and erthioneins produced by such methods are also described. The transformed cells of the present invention can convert histidine and cysteine or horsinin and cysteine to erthothionein with greater efficiency than wild-type, untransformed cells. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200128750-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20230055637-A |
priorityDate |
2012-12-21^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |